- Understanding where reducing cost versus protecting patient safety creates real tension in clinical supply
- Exploring trade-offs between speed cost and quality versus operational risk and trial integrity
- Debating when cost reduction is justified versus when it creates unacceptable risk
- Defining where efficiency gains are possible versus where quality must remain non-negotiable
- Understanding barriers to adoption
- Identifying where it adds value
- Scaling without overinvestment 15:00 Session reserved
- Understanding how IRT decisions impact clinical supply operations
- Improving responsiveness during changing enrolment and country expansion
- Reducing overproduction, waste and unnecessary shipments
- Connecting IRT data with real-time supply planning
- Sharing practical lessons from global studies
- Balancing flexibility with simplicity
- Building contingency plans that work
- Improving communication
- Understanding where compliance and operational risks most commonly arise in pharma air freight supply chains,
- Managing regulatory challenges, including Good Distribution Practice (GDP), and the role of CEIV Pharma in mitigating risks and ensuring compliance.
- Applying practical risk mitigation tools and planning strategies during transportation to avoid disruption and temperature excursions
